Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension

Free Subscription Articles published in J Perinatol Retrieve available abstracts of 34 articles: HTML format

Single Articles

February 2026
1. BYRD CE, Wren JT Jr, Desiraju S, McNamara PJ, et al
   A hemodynamic-driven approach to chronic pulmonary hypertension in congenital diaphragmatic hernia.
   J Perinatol. 2026 Feb 23. doi: 10.1038/s41372-026-02582.
   PubMed     Abstract available
   
   
   
2. FOOTE HP, Sun M, Goldstein BA, Hill KD, et al
   Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.
   J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02576.
   PubMed     Abstract available
   
   
   
3. RAMACHANDRA R, Arunamata A, Moy A, Tracy MC, et al
   Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.
   J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02580.
   PubMed     Abstract available
   
   
   
4. GOPAGONDANAHALLI KR, Tan JM, Khoo May Lyn J, Sundararaghavan S, et al
   Variable clinical and hemodynamic effect of sildenafil in extreme premature infants with bronchopulmonary dysplasia-associated pulmonary hypertension.
   J Perinatol. 2026 Feb 5. doi: 10.1038/s41372-026-02578.
   PubMed     Abstract available
   
   
   November 2025
5. GARCIA-GOZALO M, Jain A, Weisz DE, Jasani B, et al
   Can N-terminal pro-brain natriuretic peptide accurately diagnose chronic pulmonary hypertension among extremely low gestational age neonates: A Retrospective Cohort Study.
   J Perinatol. 2025 Nov 13. doi: 10.1038/s41372-025-02462.
   PubMed     Abstract available
   
   
   August 2025
6. MESSICK EA, Hart SA, Strominger J, Conroy S, et al
   Gestational age-based outcomes of neonates with Down syndrome in the neonatal intensive care unit (NICU): review of pediatric health information system (PHIS) database.
   J Perinatol. 2025 Aug 12. doi: 10.1038/s41372-025-02384.
   PubMed     Abstract available
   
   
   April 2025
7. MULLALY R, Smith A, Murphy C, Armstrong S, et al
   Characteristics and outcomes of preterm infants with early pulmonary hypertension.
   J Perinatol. 2025 Apr 11. doi: 10.1038/s41372-025-02295.
   PubMed     Abstract available
   
   
   March 2025
8. WREN JT JR, Patel N, Harting MT, McNamara PJ, et al
   Hemodynamic precision to guide surgical timing for neonates with congenital diaphragmatic hernia: a narrative review.
   J Perinatol. 2025 Mar 19. doi: 10.1038/s41372-025-02265.
   PubMed     Abstract available
   
   
   February 2025
9. MORRIS H, Reilly M, Zhang H, Dong X, et al
   Characteristics associated with death or tracheostomy in infants with bronchopulmonary dysplasia following predominant non-invasive respiratory support.
   J Perinatol. 2025 Feb 22. doi: 10.1038/s41372-025-02234.
   PubMed     Abstract available
   
   
   July 2024
10. BHATT DR, Braun D, Dizon RA, Shi JM, et al
    Retrospective study of preterm infants exposed to inhaled nitric oxide in Kaiser Permanente Southern California: morbidity, mortality and follow-up.
    J Perinatol. 2024 Jul 18. doi: 10.1038/s41372-024-02051.
    PubMed     Abstract available
    
    
    
11. SANTELICES F, Masoli D, Kattan J, Toso A, et al
    Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.
    J Perinatol. 2024 Jul 4. doi: 10.1038/s41372-024-02015.
    PubMed     Abstract available
    
    
    February 2024
12. HICKS TD, Cameron J, Wang S, Ashrafi A, et al
    Assessing the role of tracheostomy placement in bronchopulmonary dysplasia with pulmonary hypertension.
    J Perinatol. 2024 Feb 5. doi: 10.1038/s41372-024-01881.
    PubMed     Abstract available
    
    
    January 2024
13. MORONTA SC, Bischoff AR, Ryckman KK, Dagle JM, et al
    Clinical and echocardiography predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent ductus arteriosus.
    J Perinatol. 2024 Jan 31. doi: 10.1038/s41372-024-01883.
    PubMed     Abstract available
    
    
    
14. CERVERA SB, Saeed S, Luu TM, Gorgos A, et al
    Evaluation of the association between patent ductus arteriosus approach and neurodevelopment in extremely preterm infants.
    J Perinatol. 2024 Jan 26. doi: 10.1038/s41372-024-01877.
    PubMed     Abstract available
    
    
    October 2023
15. FIKE CD, Aschner JL, Avachat C, Birnbaum AK, et al
    Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
    J Perinatol. 2023 Oct 31. doi: 10.1038/s41372-023-01809.
    PubMed     Abstract available
    
    
    
16. KILMARTIN KC, Al Balushi A, Altit G, Lapointe A, et al
    Impact of persistent pulmonary hypertension and oxygenation on brain injury in neonates with neonatal encephalopathy treated with therapeutic hypothermia.
    J Perinatol. 2023 Oct 23. doi: 10.1038/s41372-023-01805.
    PubMed     Abstract available
    
    
    
17. BEER L, Rivera BK, Jama W, Slaughter JL, et al
    Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm.
    J Perinatol. 2023 Oct 18. doi: 10.1038/s41372-023-01798.
    PubMed     Abstract available
    
    
    August 2023
18. TIMBERLINE S, Bhatt A, Sunderji S, Tancredi DJ, et al
    Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.
    J Perinatol. 2023 Aug 25. doi: 10.1038/s41372-023-01762.
    PubMed     Abstract available
    
    
    
19. ZHU F, Ibarra Rios D, Joye S, Baczynski M, et al
    Cardiopulmonary physiological effects of diuretic therapy in preterm infants with chronic pulmonary hypertension.
    J Perinatol. 2023 Aug 7. doi: 10.1038/s41372-023-01742.
    PubMed     Abstract available
    
    
    
20. OSMAN A, Halling C, Crume M, Al Tabosh H, et al
    Meconium aspiration syndrome: a comprehensive review.
    J Perinatol. 2023 Aug 5. doi: 10.1038/s41372-023-01708.
    PubMed     Abstract available
    
    
    
21. STEFLIK HJ, Wessler LA, Shugart WW, Wagner CL, et al
    Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
    J Perinatol. 2023;43:1045-1046.
    PubMed    
    
    
    February 2023
22. SHARMA P, Beam K, Levy P, Beam AL, et al
    PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.
    J Perinatol. 2023;43:257-258.
    PubMed    
    
    
    December 2022
23. MURPHY C, Bussmann N, Staunton D, McCallion N, et al
    The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance.
    J Perinatol. 2022;42:1697-1698.
    PubMed    
    
    
    November 2022
24. EL-KHUFFASH A, McNamara PJ, Breatnach C, Bussmann N, et al
    The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1).
    J Perinatol. 2022 Nov 16. pii: 10.1038/s41372-022-01562.
    PubMed     Abstract available
    
    
    September 2022
25. STEFLIK HJ, Brinton DL, Corrigan C, Wagner CL, et al
    Costs associated with acute kidney injury in critically Ill neonates with patent Ductus arteriosus: pediatric health information system (PHIS) analysis.
    J Perinatol. 2022 Sep 7. pii: 10.1038/s41372-022-01499.
    PubMed     Abstract available
    
    
    August 2022
26. DE CARVALHO NUNES G, Wutthigate P, Simoneau J, Dancea A, et al
    The biventricular contribution to chronic pulmonary hypertension of the extremely premature infant.
    J Perinatol. 2022 Aug 25. pii: 10.1038/s41372-022-01497.
    PubMed     Abstract available
    
    
    
27. PARK L, Donohue L, Lakshminrusimha S, Sankaran D, et al
    Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
    J Perinatol. 2022 Aug 15. pii: 10.1038/s41372-022-01489.
    PubMed    
    
    
    June 2022
28. AVITABILE CM, Zhang X, Ampah SB, Wang Y, et al
    Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2022 Jun 8. pii: 10.1038/s41372-022-01421.
    PubMed     Abstract available
    
    
    May 2022
29. MEMON N, Griffin I
    Correspondence: "Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort".
    J Perinatol. 2022;42:692.
    PubMed    
    
    
    April 2022
30. GIEN J, Kinsella JP, Behrendt NJ, Zaretsky MV, et al
    Improved survival for infants with severe congenital diaphragmatic hernia.
    J Perinatol. 2022 Apr 23. pii: 10.1038/s41372-022-01397.
    PubMed     Abstract available
    
    
    
31. CARPENTER RJ, Srdanovic N, Rychlik K, Sen SK, et al
    The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia.
    J Perinatol. 2022 Apr 9. pii: 10.1038/s41372-022-01386.
    PubMed     Abstract available
    
    
    
32. SALLMON H, Koestenberger M, Avian A, Reiterer F, et al
    Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
    J Perinatol. 2022 Apr 1. pii: 10.1038/s41372-022-01374.
    PubMed     Abstract available
    
    
    January 2022
33. DILLARD J, Pavlek LR, Korada S, Chen B, et al
    Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
    J Perinatol. 2022;42:37-44.
    PubMed     Abstract available
    
    
    October 2021
34. YURTTUTAN S, Gullu UU
    Neonatal AKI in late preterm infants with patent ductus arteriosus.
    J Perinatol. 2021;41:2383-2384.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum